Tower Research Capital (TRC)’s Alexion Pharmaceuticals ALXN Stock Holding History

Tower Research Capital (TRC)’s Portfolio ALXN Stock Details ALXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-9,367	Closed	-$1.72M	–	6635
2021 Q2	$1.72M	Sell	9,367 -19,194	-67%	-$3.29M	0.04%	366
2021 Q1	$4.37M	Buy	28,561 +23,615	+477%	+$3.65M	0.07%	244
2020 Q4	$773K	Sell	4,946 -4,716	-49%	-$606K	0.02%	669
2020 Q3	$1.11M	Buy	9,662 +2,791	+41%	+$301K	0.01%	896
2020 Q2	$772K	Buy	6,871 +5,992	+682%	+$636K	0.03%	690
2020 Q1	$79K	Sell	879 -905	-51%	-$88.8K	﹤0.01%	1088
2019 Q4	$193K	Sell	1,784 -2,094	-54%	-$224K	0.02%	606
2019 Q3	$380K	Buy	3,878 +1,875	+94%	+$211K	0.03%	692
2019 Q2	$263K	Sell	2,003 -2,017	-50%	-$260K	0.02%	742
2019 Q1	$543K	Buy	4,020 +3,721	+1,244%	+$463K	0.03%	553
2018 Q4	$29K	Buy	+299	New	+$35.3K	﹤0.01%	1663
2018 Q3	–	Sell	-12,315	Closed	-$1.53M	–	4449
2018 Q2	$1.53M	Buy	12,315 +11,984	+3,621%	+$1.4M	0.09%	219
2018 Q1	$37K	Buy	331 +272	+461%	+$32.5K	﹤0.01%	1857
2017 Q4	$7K	Buy	+59	New	+$7.18K	﹤0.01%	2775
2017 Q3	–	Sell	-1,793	Closed	-$218K	–	4397
2017 Q2	$218K	Buy	1,793 +1,761	+5,503%	+$205K	0.02%	324
2017 Q1	$4K	Sell	32 -1,397	-98%	-$180K	﹤0.01%	2386
2016 Q4	$175K	Buy	+1,429	New	+$175K	0.02%	686
2016 Q3	–	Sell	-203	Closed	-$24K	–	4792
2016 Q2	$24K	Sell	203 -280	-58%	-$39.7K	﹤0.01%	2103
2016 Q1	$67K	Buy	483 +343	+245%	+$50.4K	0.01%	645
2015 Q4	$27K	Sell	140 -1,060	-88%	-$185K	﹤0.01%	998
2015 Q3	$188K	Buy	+1,200	New	+$219K	0.02%	302
2015 Q2	–	Sell	-871	Closed	-$151K	–	5310
2015 Q1	$151K	Buy	+871	New	+$158K	0.02%	582
2014 Q4	–	Sell	-1,978	Closed	-$328K	–	4966
2014 Q3	$328K	Buy	+1,978	New	+$325K	0.04%	354
2014 Q2	–	Sell	-325	Closed	-$49K	–	4893
2014 Q1	$49K	Sell	325 -329	-50%	-$52.3K	0.01%	1111
2013 Q4	$87K	Buy	654 +321	+96%	+$38.5K	0.01%	945
2013 Q3	$38K	Sell	333 -52	-14%	-$5.71K	﹤0.01%	2167
2013 Q2	$36K	Buy	+385	New	+$37.1K	﹤0.01%	1196

Other funds holding ALXN

BCI

Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return

NICM

Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return

TAIM

TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return

Barclays London, United Kingdom $280B AUM 33.63% 1-Year Est. Return

Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return

CFO

CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return

MAM

Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return